comprehensive -WSS

comprehensive

author：knowledge 2025-09-01 15:22:23 - browse：828

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： CDC picks Alphabet's Verily for wasterwater surveillance contract

WSS

RSV injection headlines need to be accurate for good uptake

6 solutions to address cancer drug shortages and others

European officials brace for rough respiratory virus season

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

With Roe v Wade overturned, abortion providers work to adapt

Health insurers' Q3 question: how much care are people getting?

Wikipedia

comprehensive

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Poor hospice wound care hurts patients and families

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Some top drug companies are starting to take action on climate

Peter Hotez and the public health issue of online harassment

Lawsuit highlights wrinkle for disputes over surprise medical bills

George Santos makes 1st court appearance after pleading not guilty to 13 counts

6 solutions to address cancer drug shortages and others

focus

The United States is paying nearly triple for new Covid vaccines

World's first CRISPR

Flu, Covid vaccination rates decline, new survey data show

PBM reforms clear House panel

CDC picks Alphabet's Verily for wasterwater surveillance contract

Hospitals look to new technology to keep health care workers safe

explore

entertainment

knowledge

explore